Hyperliquid Adds Optional Wallet Allowlists for Builder Markets via HIP-3* Testnet Extension

Bitcoin

Long-term, advancements in cell-free protein synthesis could accelerate biotech innovation, but they do not alter the fundamental drivers of crypto demand (monetary policy, adoption, liquidity). The crypto market is currently driven by macro sentiment and BTC dominance, with altcoins underperforming.

A robotic, cell-free platform for rapid prototyping of genetic codes was announced in Nature, enabling translation of proteins with reassigned codons and non-standard amino acids without altering living genomes.

Cell-Free Genetic Code Platform in Nature Draws 'Testnet' Parallels

The Cell-Free Genetic Code Platform Is a Testnet for Biological Smart Contracts—Not Just Biotech

Pi Network's Protocol 27 Lands on Testnet, Mainnet Upgrade Set for Sept 15

Real Launches 90-Day $ASSET Staking Campaign With 75,000 USDC Pool

BEP-675 Proposal Aims to Lift BNB Chain Throughput by 88%

Circle Taps Visa, Mastercard, BlackRock as Validators for Arc Platform Launch in September

Solana Cuts Slot Time to 350ms on Testnet in First Reduction

Cardano Connects to Injective via IBC on Testnet

Hyperliquid Enables Permissionless Prediction Markets on Testnet; HYPE Token Drops Below $55

Pi Network Tests Launchpad Model With SLICE Token on Testnet

Litecoin's LitVM Hits 140 Million Testnet Transactions, Paving Way for DeFi

Sui Foundation, Mysten Labs Launch Hashi Testnet for Bitcoin-Collateralized Lending

Hashi Launches Bitcoin Lending Testnet on Sui

Stacks Launches PoX-5 Testnet With Self-Custody Bitcoin Staking, Mainnet Fork Set for July 29

Hashi Testnet Goes Live on Sui With Guardian Layer for Bitcoin Collateral

Circle Builds Four-Layer Financial Stack Around Arc, Aims to Challenge Tether's Dominance

Hyperliquid to Launch Decentralized Prediction Markets in HIP-4 Upgrade

Tezos X Launches EVM Integration to Boost Scalability and Interoperability